Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Aug 20;112(1):169–178. doi: 10.1016/j.ijrobp.2021.08.019

Table 3:

Multivariable Cox modeling of OS and PFS for lymphopenia. Age is analyzed continuously per decade.

COVARIABLE OVERALL SURVIVAL N=101 PROGRESSION-FREE SURVIVAL N=101

Hazard Ratio (95% CI) P Hazard Ratio (95% CI) P
PRE-TREATMENT LYMPHOCYTE COUNT
> 1.5 K/μL Reference Reference -
≤ 1.5 K/μL 2.85 (0.94, 8.62) 0.06 1.72 (0.69, 4.31) 0.25
IG-IMRT
NO Reference Reference -
YES 0.76 (0.23, 2.49) 0.66 0.98 (0.41, 2.35) 0.97
AGE (PER 10 YEARS) 1.06 (0.69, 1.63) 0.79 0.91 (0.64, 1.29) 0.60
FIGO STAGE
STAGE I-IIA Reference Reference -
STAGE IIB 0.54 (0.16, 1.89) 0.34 0.75 (0.28, 2.04) 0.58
STAGE III-IVA 1.07 (0.19, 6.14) 0.94 0.76 (0.18, 3.20) 0.71